Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8023997 | 0.76 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14 | |
| SCHEMBL8023996 | 0.76 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14 | |
| SCHEMBL8017333 | 0.70 | SMN1; SMN2 (0.38) | SMN1; SMN2CA14 | |
| SCHEMBL784551 | 0.67 | SMN1; SMN2 (0.52) | SMN1; SMN2CA14 | |
| SCHEMBL13946795 | 0.67 | SMN1; SMN2 (0.52) | SMN1; SMN2CA14 | |
| SCHEMBL13176813 | 0.65 | SMN1; SMN2 (0.34) | SMN1; SMN2CA14 | |
| SCHEMBL8871226 | 0.65 | — | — | |
| SCHEMBL7123594 | 0.65 | — | — | |
| SCHEMBL8498697 | 0.65 | — | — | |
| SCHEMBL8500718 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5175344-A | Anticonvulsants, anxiolytic agents | CIBA-GEIGY CORPORATION (US) | 1992-12-29 | — | — | US | disclosed |
| US-5051413-A | For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions | CIBA-GEIGY CORPORATION (US) | 1991-09-24 | — | — | US | disclosed |